-
FDA Approvals Summary - July 2025
FDA Drug Approvals
FDA approved several new drugs in July 2025, including treatments for phenylketonuria, chronic hand eczema, hereditary angioedema, EGFR-mutated lung cancer, and relapsed multiple myeloma, offering new hope for patients.
-
-
-
FDA Approvals Summary - April 2025
FDA Drug Approvals
Discover the FDA's new drug approvals in April 2025, including treatments for IgAN, nasopharyngeal carcinoma, myasthenia gravis, and colorectal cancer. Learn about groundbreaking therapies like Vanrafia, Penpulimab-KCQX, and Imaavy.
-
-
-
-
FDA Approved Summay - Januaray 2025
FDA Drug Approvals
Explore FDA drug approvals from January 2025, including treatments for Crohn's disease, colorectal cancer, Alzheimer's, migraine, and more. Key approvals from Eli Lilly, Amgen, AstraZeneca, and others reshape patient care options.
-
-
FDA 2025 Q1 Approval Overview (I)
FDA Drug Approvals
The FDA's 2025 Q1 approval pipeline includes promising treatments for diabetes, cancer, and central nervous system disorders. Key candidates include Ozempic for kidney disease, Subvenite for epilepsy, and TX05, a HER2-targeted cancer biosimilar.
胶南市|
新化县|
昆山市|
响水县|
桦南县|
太白县|
巴东县|
馆陶县|
麻江县|
宜春市|
博乐市|
泗水县|
托里县|
横峰县|
额敏县|
常山县|
黔西县|
辽源市|
浪卡子县|
漯河市|
镶黄旗|
天全县|
抚宁县|
青岛市|
黄龙县|
嵊州市|
凌云县|
通州区|
克山县|
济宁市|
涟源市|
剑河县|
红河县|
乃东县|
镇康县|
商洛市|
萨嘎县|
凤翔县|
噶尔县|
宣威市|
桐梓县|